logo
Casa
Chi siamo
Profilo aziendale
Giro della fabbrica
Controllo di qualità
prodotti

Derivati della cellulosa

Derivati di amido

Rivestimento per compresse

sale inorganico

Sfere di zucchero farmaceutiche

Serie di resine

Eccipienti farmaceutici

diossido di silicio

Stearato del magnesio

CMC Carboximetilcellulosa

Glicolato dell'amido del sodio

HPMC dell'ipromellosio

Cellulosa microcristallina MCC

Amido trattato con acido

Agente di rivestimento composto

Apparecchi per l'ispessimento
Video
Eventi
Notizie
Casi
Contattici
Ora chiacchieri
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
العربية
हिन्दी
Türkçe
indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
Casa
Chi siamo
prodotti

Derivati della cellulosa

Derivati di amido

Rivestimento per compresse

sale inorganico

Sfere di zucchero farmaceutiche

Serie di resine

Eccipienti farmaceutici

diossido di silicio

Stearato del magnesio

CMC Carboximetilcellulosa

Glicolato dell'amido del sodio

HPMC dell'ipromellosio

Cellulosa microcristallina MCC

Amido trattato con acido

Agente di rivestimento composto

Apparecchi per l'ispessimento
Video
Eventi
Notizie
Casi
Contattici
citazione
bandiera bandiera

DETTAGLI DI NOTIZIE
Casa > Notizie >

Notizie aziendali su Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

Eventi

Notizie

Casi
Contattici
Ms. Haileeping
haileeping@sunhere-excipients.com
86-0554-2796186
Contatto ora

Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

2026-02-05

Major Announcement: Sunhere Pharmaceutical Excipients Successfully Passes U.S. FDA On-Site Inspection, 

Marking Another Milestone in Its Global Layout!


The company has successfully completed the U.S. FDA on-site inspection and received the official Establishment Inspection Report (EIR) confirmation!


ultime notizie sull'azienda Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection 0


This inspection covered the entire system, including quality management, production, facilities and equipment, quality control, and materials management. It marks the first time the company has obtained this authoritative FDA qualification. This not only signifies that Sunhere Pharmaceutical Excipients' GMP management system fully aligns with top international standards, but also means its products hold the core passport to enter the global market.


ultime notizie sull'azienda Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection 1


As a leading domestic manufacturer of oral solid dosage form pharmaceutical excipients, Sunhere Pharmaceutical Excipients has continuously consolidated its global competitive barriers. Moving forward, the company will empower global customers with higher standards, advance the domestic substitution of pharmaceutical excipients, and accelerate its expansion into the global pharmaceutical ecosystem!

bandiera
DETTAGLI DI NOTIZIE
Casa > Notizie >

Notizie aziendali su-Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

Eventi

Notizie

Casi

Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

2026-02-05

Major Announcement: Sunhere Pharmaceutical Excipients Successfully Passes U.S. FDA On-Site Inspection, 

Marking Another Milestone in Its Global Layout!


The company has successfully completed the U.S. FDA on-site inspection and received the official Establishment Inspection Report (EIR) confirmation!


ultime notizie sull'azienda Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection 0


This inspection covered the entire system, including quality management, production, facilities and equipment, quality control, and materials management. It marks the first time the company has obtained this authoritative FDA qualification. This not only signifies that Sunhere Pharmaceutical Excipients' GMP management system fully aligns with top international standards, but also means its products hold the core passport to enter the global market.


ultime notizie sull'azienda Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection 1


As a leading domestic manufacturer of oral solid dosage form pharmaceutical excipients, Sunhere Pharmaceutical Excipients has continuously consolidated its global competitive barriers. Moving forward, the company will empower global customers with higher standards, advance the domestic substitution of pharmaceutical excipients, and accelerate its expansion into the global pharmaceutical ecosystem!

Collegamento rapido
Casa Chi siamo prodotti Video Notizie Casi Contattici
Contatto rapido

Indirizzo

ZONE di sviluppo economico e tecnologico,HUAINAN,ANHUI 232007,CINA

Telefono

86-0554-2796186

La nostra newsletter
Iscriviti alla nostra newsletter per sconti e altro.
Norme sulla privacy |  Mappa del sito  | Buona qualità della Cina Derivati della cellulosa Fornitore. © di Copyright 2024-2026 Anhui Sunhere Pharmaceutical Excipients Co., Ltd. . Tutti i diritti riservati.